Published in Chest on August 01, 2000
Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol (2014) 1.64
Does percutaneous dilatational tracheostomy increase the incidence of sternal wound infection - a single center retrospective of 4100 cases. J Cardiothorac Surg (2015) 1.38
The effect of surgical site infection on older operative patients. J Am Geriatr Soc (2009) 1.24
Mycotic ascending aortic pseudoaneurysm secondary to pseudomonas mediastinitis at the aortic cannulation site. Tex Heart Inst J (2003) 1.23
Risk factors for mediastinitis after cardiac surgery - a retrospective analysis of 1700 patients. J Cardiothorac Surg (2007) 1.17
Bilateral sternobronchial fistula after coronary surgery--are the retained epicardial pacing wires responsible? A case report. J Cardiothorac Surg (2009) 1.05
First experience with a new negative pressure incision management system on surgical incisions after cardiac surgery in high risk patients. J Cardiothorac Surg (2011) 0.96
Use of incisional negative pressure wound therapy on closed median sternal incisions after cardiothoracic surgery: clinical evidence and consensus recommendations. Med Sci Monit (2014) 0.96
Preventing deep wound infection after coronary artery bypass grafting: a review. Tex Heart Inst J (2013) 0.95
Surgical site infections--economic consequences for the health care system. Langenbecks Arch Surg (2011) 0.93
Secondary omental and pectoralis major double flap reconstruction following aggressive sternectomy for deep sternal wound infections after cardiac surgery. J Cardiothorac Surg (2011) 0.90
First evidence of sternal wound biofilm following cardiac surgery. PLoS One (2013) 0.89
Incidence, microbiological findings, and clinical presentation of sternal wound infections after cardiac surgery with and without local gentamicin prophylaxis. Eur J Clin Microbiol Infect Dis (2007) 0.89
Establishing the case for minimally invasive, robotic-assisted CABG in the treatment of multivessel coronary artery disease. Heart Surg Forum (2009) 0.86
Negative Pressure Wound Therapy on Closed Surgical Wounds With Dead Space: Animal Study Using a Swine Model. Ann Plast Surg (2016) 0.84
Prevalence of major infections and adverse outcomes among hospitalized. ST-elevation myocardial infarction patients in Florida, 2006. BMC Cardiovasc Disord (2011) 0.83
Clinical and Molecular Features of Decreased Chlorhexidine Susceptibility among Nosocomial Staphylococcus aureus Isolates at Texas Children's Hospital. Antimicrob Agents Chemother (2015) 0.82
Pressurized pulse irrigation with saline reduces surgical-site infections following major hepatobiliary and pancreatic surgery: randomized controlled trial. World J Surg (2014) 0.82
Factors associated with prolonged length of stay following cardiac surgery in a major referral hospital in Oman: a retrospective observational study. BMJ Open (2016) 0.82
Postoperative surgical chest and leg incision sites using platelet gel: a retrospective study. J Extra Corpor Technol (2008) 0.79
Prospective, randomized, single blinded pilot study of a new FlatWire based sternal closure system. J Cardiothorac Surg (2014) 0.79
Evaluating the optimal timing of surgical antimicrobial prophylaxis: study protocol for a randomized controlled trial. Trials (2014) 0.79
An implementation on the social cost of hospital acquired infections. Int J Clin Exp Med (2015) 0.78
Septic rupture of the ascending aorta after aortocoronary bypass surgery. J Cardiothorac Surg (2008) 0.77
Improving public reporting and data validation for complex surgical site infections after coronary artery bypass graft surgery and hip arthroplasty. Open Forum Infect Dis (2014) 0.77
Severe Obesity Is Associated With Increased Risk of Early Complications and Extended Length of Stay Following Coronary Artery Bypass Grafting Surgery. J Am Heart Assoc (2016) 0.75
Which Kind of Provider's Operation Volumes Matters? Associations between CABG Surgical Site Infection Risk and Hospital and Surgeon Operation Volumes among Medical Centers in Taiwan. PLoS One (2015) 0.75
Comparison of the Effectiveness of Continuous versus Intermittent Cefazolin for the Prevention of Infection after Off-Pump Coronary Artery Bypass Graft. J Tehran Heart Cent (2014) 0.75
The protective effect of topical rifamycin treatment against sternal wound infection in diabetic patients undergoing on-pump coronary artery bypass graft surgery. Cardiovasc J Afr (2014) 0.75
Does Body Mass Index Affect Mortality in Coronary Surgery? Open Cardiovasc Med J (2016) 0.75
Bacterial contamination of suction catheter tips during aortic valve replacement surgery: a prospective observational cohort study. Patient Saf Surg (2015) 0.75
Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery. Antimicrob Agents Chemother (2011) 0.75
Surgical site infections following coronary artery bypass graft procedures: 10 years of surveillance data. BMC Infect Dis (2014) 0.75
Socioeconomic effects of surgical site infection after cardiac surgery in Japan. Surg Today (2014) 0.75
The OneTogether collaborative approach to reduce the risk of surgical site infection: identifying the challenges to assuring best practice. J Infect Prev (2015) 0.75
Timing of preoperative antibiotic prophylaxis in 54,552 patients and the risk of surgical site infection: A systematic review and meta-analysis. Medicine (Baltimore) (2017) 0.75
Nosocomial infections and antibiotic resistance pattern in open-heart surgery patients at Imam Ali Hospital in Kermanshah, Iran. GMS Hyg Infect Control (2017) 0.75
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science (1986) 11.74
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest (1999) 7.40
Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med (1986) 6.52
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A (1991) 6.13
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis (1992) 4.98
Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J Virol (1992) 4.72
Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science (1997) 4.57
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50
Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells. J Cell Biol (2001) 3.44
Antibiotic resistance in the intensive care unit. Ann Intern Med (2001) 3.40
Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. J Virol (1994) 3.33
The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med (1990) 3.28
Measurements of the concentration and composition of nuclei for cirrus formation. Proc Natl Acad Sci U S A (2003) 3.18
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol (1987) 2.84
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun (2001) 2.68
The Rapid Syndrome Validation Project (RSVP). Proc AMIA Symp (2001) 2.67
Evaluation of rooms with negative pressure ventilation used for respiratory isolation in seven midwestern hospitals. Infect Control Hosp Epidemiol (1993) 2.65
Antimicrobial misuse in patients with positive blood cultures. Am J Med (1989) 2.45
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis (2000) 2.37
Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol (1999) 2.35
Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med (2001) 2.35
Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension. Eur Respir J (2009) 2.26
Mechanical ventilation with or without 7-day circuit changes. A randomized controlled trial. Ann Intern Med (1995) 2.26
The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med (1999) 2.18
NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med (1991) 2.15
Criteria for outpatient management of proximal lower extremity deep venous thrombosis. Chest (1999) 2.06
Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination. Lancet (1995) 2.06
Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. J Immunol (1990) 2.05
Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol (1999) 2.03
An expert system for culture-based infection control surveillance. Proc Annu Symp Comput Appl Med Care (1993) 1.98
Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun (2001) 1.97
High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med (1993) 1.97
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol (1995) 1.91
A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis (1997) 1.90
Organic aerosol formation downwind from the Deepwater Horizon oil spill. Science (2011) 1.89
CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc Natl Acad Sci U S A (1990) 1.88
Automated system for identifying potential dosage problems at a large university hospital. Am J Health Syst Pharm (1997) 1.75
A revised equation relating DNA buoyant density to guanine plus cytosine content. J Biochem Biophys Methods (1980) 1.74
Predicting death after CPR. Experience at a nonteaching community hospital with a full-time critical care staff. Chest (1995) 1.73
Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation (2000) 1.72
Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature (1994) 1.69
Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro. J Virol (1998) 1.67
Report of spores of Henneguya salminicola (Myxozoa) in human stool specimens: possible source of confusion with human spermatozoa. J Clin Microbiol (1997) 1.67
The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest (1997) 1.62
Identification of HIV vaccine candidate peptides by screening random phage epitope libraries. Virology (1993) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep (1992) 1.59
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J Exp Med (1994) 1.55
Antiviral chemoprophylaxis after occupational exposure to human immunodeficiency virus: why, when, where, and what. Am J Ophthalmol (1997) 1.52
Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol (1999) 1.52
The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest (1995) 1.50
Seasonal affective disorder: response to light as measured by electroencephalogram, melatonin suppression, and cerebral blood flow. Br J Psychiatry (1993) 1.48
The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest (2001) 1.48
Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.47
Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. J Infect Dis (1998) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
The Queensland cholera incident of 1977. 2. The epidemiological investigation. Bull World Health Organ (1980) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells. J Immunol (1991) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding. J Immunol (1988) 1.34
Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax (2005) 1.33
A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. J Virol (1995) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest (1998) 1.32
Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol (1993) 1.30
Primary grade 1 transitional cell carcinoma of the renal pelvis and ureter. J Urol (1980) 1.29
Macrophage factor controlling differentiation of B cells. J Immunol (1979) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Delays in the suspicion and treatment of tuberculosis among hospitalized patients. Ann Intern Med (1999) 1.27
Understanding patient willingness to recommend and return: a strategy for prioritizing improvement opportunities. Jt Comm J Qual Improv (1999) 1.25
A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9. J Infect Dis (1999) 1.24
Primary airway epithelial cell culture from lung transplant recipients. Eur Respir J (2005) 1.23
Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes. J Exp Med (1992) 1.23
Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy. HIV Med (2006) 1.21
A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers. J Infect Dis (2001) 1.20
In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J Virol (1998) 1.20
Management of high grade transitional cell cancer of the upper urinary tract. J Urol (1981) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis (1996) 1.18
Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition. J Exp Med (1990) 1.17
Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. J Immunol (1992) 1.16
Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. Ann Intern Med (1987) 1.16
Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis (1998) 1.16
GM-2 gangliosidosis (Sandhoff's disease): two year follow-up by MRI. Neuroradiology (1994) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Induction of phenotypic lymphocyte differentiation in LPS unresponsive mice by an LPS-induced serum factor and by lipid A-associated protein. J Immunol (1977) 1.13
Transplant nephrectomy over 20 years: factors involved in associated morbidity and mortality. J Urol (1994) 1.11
B-cell activation by lipopolysaccharide. Distinct pathways for induction of mitosis and antibody production. J Exp Med (1977) 1.11
Determinants of pulmonary function in patients undergoing coronary bypass operations. Ann Thorac Surg (1990) 1.10
Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1992) 1.09
Severe airway disease due to inhalation of fumes from cleansing agents. Chest (1976) 1.09